학술논문
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
Document Type
Artikel
Author
Menghrajani, K; Gomez-Arteaga, A; Madero-Marroquin, R; Zhang, MJ; Bo-Subait, K; Sanchez, J; Wang, HL; Aljurf, M; Assal, A; Bacher, VU; Badawy, SM; Bejanyan, N; Bhatt, VR; Bredeson, C; Byrne, M; Castillo, P; Cerny, J; Chhabra, S; Ciurea, SO; DeFilipp, Z; Farhadfar, N; Gadalla, S; Gale, RP; Ganguly, S; Gowda, L; Grunwald, MR; Hashmi, S; Hildebrandt, G; Kanakry, CG; Kansagra, A; Khimani, F; Krem, M; Lazarus, H; Liu, HT; Martino, R; Michelis, FV; Nathan, S; Nishihori, T; Olsson, R; Reshef, R; Rizzieri, D; Rowe, JM; Savani, BN; Seo, S; Sharma, A; Solh, M; Ustun, C; Verdonck, LF; Hourigan, C; Sandmaier, B; Litzow, M; Kebriaei, P; Weisdorf, D; Zhang, YM; Tallman, MS; Saber, W
Source
Blood advances. 6(3):828-847
Subject
Language
English
English
English
ISSN
2473-9537